Maphunziro Ine nzeru mankhwala a JYMed patsogolo kwambiri, Laipushutai akuyembekezeka kukhala mzere woyamba wa UC mankhwala.

Pa June 29, 2017, chitukuko cha Laipushutai, kalasi Ine nzeru mankhwala ndi chitukuko mukupanga wa JYMed ndi Guangzhou Linkhealth Medical Technology Co., Ltd., apita patsogolo kwambiri. Mankhwala a IND kulengeza walandiridwa ndi CFDA.

JYMed ndi Guangzhou Linkhealth Medical Technology Co., Ltd. anafika pangano mgwirizano mu 2016 kuti ichitikire kukhala mankhwala mu China. Mitundu wamaliza POC maphunziro matenda mu EU ndipo zimatheka chitetezo ndi chikhululukiro wabwino mitengo. Onse FDA ndi EMA kuzindikira mtundu ingagwiritsidwe ntchito mankhwala pa ine / II mzere, ndi chofunikila adzapatsidwa ku mpumulo ndi kuchiza odwala ndi zolimbitsa anam'peza matenda a m'matumbo mwa amatsata matenda mayesero a CFDA.

Anam'peza matenda a m'matumbo (UC) ndi aakulu, si yeniyeni yotupa matenda amenewa amapezeka mu rectum ndi m'matumbo. Malinga ndi kafukufuku, mlingo zochitika za UC ndi 1.2 kuti 20,3 milandu / 100,000 munthu pachaka ndi kuchuluka kwa UC ndi 7.6 kuti 246,0 milandu / anthu 10,000 pa chaka. Kuchuluka kwa UC ndi ambiri mwa achinyamata. Msika UC ali mwaunyinji ndi kufunika kwa mankhwala, ndipo tipitirizebe kukhala mkulu kukula azimuth m'tsogolo. Padakali UC woyamba mzere mankhwala makamaka zochokera mesalazine timadzi, ndi mankhwala wachiwiri mzere monga immunosuppressants ndi kwachilengedwenso chitetezo monoclonal. Mesalazine ali ndi malonda buku la 1 biliyoni mu China ndi US $ 2 biliyoni mu United States mu 2015. Laipushutai ali ayankhe bwino zizindikiro UC ndipo si owopsa kuposa panopa mankhwala oyamba-mzere. Iwo ali wabwino msika ntchito ndipo akuyembekezeka kukhala woyamba mzere UC mankhwala.

333661

 


Post nthawi: Mar-02-2019
WhatsApp Online Chat!